Will IVF Hartmann stock go up?

According to Danelfin AI, IVF Hartmann has today an AI Score of 7/10 (Buy rating), because its probability of beating the market in 3 months (55.60%) is +5.91% vs. the average probability (49.69%) of all European stocks.

Is it a good time to buy, sell, or hold IVF Hartmann stock right now?

IVF Hartmann has today a Buy rating (AI Score 7/10), according to Danelfin AI. Its probability of beating the market in 3 months (55.60%) is +5.91% vs. the average probability (49.69%) of all European stocks, based on our AI-powered analysis. You can find more details on whether IVF Hartmann stock is a good buy .

What is going on with IVF Hartmann stock in the last 3 months?

The IVF Hartmann stock performance in the last quarter has been -6.90%.

Does IVF Hartmann offer dividend payments?

Yes, IVF Hartmann stock dividend yield is 2.97%.

What is the current market capitalization of IVF Hartmann?

IVF Hartmann's market cap is CHF 296.83M, as of 2026-07-02 08:00.

IVF Hartmann Holding AG (VBSN.SW) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

VBSN.SW AI-Powered Stock Analysis

AI Score Explanation

AI Score

Buy

Fundamental
Technical
Sentiment
Low Risk

According to Danelfin’s proprietary AI model, IVF Hartmann Holding AG today receives an AI Score of 7/10, which translates to a Buy rating. The stock has a 56% probability of outperforming the European market in the next 3 months, which is 6% higher than the average probability of any stock (50%). The top positive contributors include the Chart Pattern (504d) (+1.37%), Alpha YTD (+1.19%), and Chart Pattern (180d) (+0.93%), all boosting the probability. On the negative side, the Industry (GICS) being Health Care Equipment & Supplies detracts (-2.87%), and Other Equity (-0.39%) and Chart Pattern (90d) (-0.28%) also weigh down the score. Notable data points include Diluted EPS in the top 10% (value 3.43) and Other Current Assets QoQ Growth also in the top 10% (value 308.1%), both strongly positive. However, Other Equity is in the bottom 20% (value -29,136,000), a detractor. The Fear & Greed Index at 31 (extreme fear) adds a contrarian positive (+0.82%). Overall, the strong profitability and growth signals outweigh the industry and equity concerns, supporting the Buy rating.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Momentum+5.04%
Direction and strength of recent price movements
Earnings Quality+1.15%
Stability and reliability of reported earnings
Growth+0.65%
Expected pace of revenue and earnings expansion
Valuation+0.57%
How the stock is priced relative to its fundamentals
Profitability+0.29%
Profitability and operating efficiency metrics
Volatility+0.24%
How much the stock price tends to fluctuate
Financial Strength+0.22%
Balance sheet strength and financial resilience

Sentiment-2.10%
How analysts and the market view the stock
Size & Liquidity-0.16%
Company size and trading liquidity

VBSN.SW probability advantage of beating the market (3M):

+5.91%

AI Score

Buy

IVF Hartmann (VBSN.SW) has an AI Score of 7/10 (Buy) because, according to an overall analysis, it has a probability advantage of +5.91% of beating the market (STOXX 600) in the next 3 months. This advantage is calculated as the difference between the average probability of any European stock (49.69%) and the probability of VBSN.SW (55.60%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any European stock of beating the market (3M)49.69%
VBSN.SW probability advantage of beating the market (3M)+5.91%
VBSN.SW probability of beating the market (3M)55.60%

VBSN.SW probability advantage of beating the market (3M): +5.91%

The AI-powered overall analysis of IVF Hartmann (VBSN.SW) is based on the 34 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 24 months (alpha signals). These alpha signals explain the probability advantage of VBSN.SW:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Sentiment	Industry (GICS)	Health Care Equipment & Supplies	N/A	-2.87%
Technical	Chart Pattern (504d)	figure_46	N/A	+1.37%
Technical	Alpha YTD	-0.20%		+1.19%
Technical	Chart Pattern (180d)	figure_75	N/A	+0.93%
Technical	Chart Pattern (252d)	figure_77	N/A	+0.85%
Sentiment	Fear & Greed Index (CNN)	31	N/A	+0.82%
Fundamental	Consolidated Net Income / Loss	8.24M		+0.80%
Technical	Chart Pattern (120d)	figure_90	N/A	+0.70%
Fundamental	Diluted EPS	3.43		+0.65%
Technical	Avg. Last Decile Drawdown (1Y)	-0.04		+0.64%
Fundamental	Upgrade to unlock			+0.56%
Fundamental	Upgrade to unlock			+0.56%
Fundamental	Upgrade to unlock			-0.39%
Fundamental	Upgrade to unlock			+0.29%
Technical	Upgrade to unlock			-0.28%

Rest of Alpha Signals: +0.65%

VBSN.SW probability advantage of beating the market (3M)Total:+5.91%
VBSN.SW AI Score

Significant changes Vs previous day

VBSN.SW Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:CHF 128
Horizon: 3 months
Stop Loss:CHFXXXXXPro (XXXXXPro) or AI Score < 7/10
Take Profit:CHFXXXXXPro (XXXXX
Pro
) or AI Score < 7/10

VBSN.SW Proven Buy Signal & Price Forecast

This is the price chart for VBSN.SW from January 1, 2026 until today. The chart indicates, in green, the 12 days when the stock received a Buy/Strong Buy rating (buy signals, AI Score 7 to 10).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Buy signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Buy signals

Forecast:

1 Month
3 Months
6 Months
1 Year

VBSN.SW Average Past Performance & Win Rate

Three months after its 745 Buy signals since July 2026, VBSN.SW had an average performance of xxxxxx and a xxxxxx Win rate (positive performance).

745 Past VBSN.SW Buy Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				-1.00%
Average Alpha				-14.45%
Win Rate (% Positive Perf.)				50.32%
% Positive Alpha				14.39%

VBSN.SW Frequently Asked Questions

Will IVF Hartmann stock go up?
According to Danelfin AI, IVF Hartmann has today an AI Score of 7/10 (Buy rating), because its probability of beating the market in 3 months (55.60%) is +5.91% vs. the average probability (49.69%) of all European stocks.
Is it a good time to buy, sell, or hold IVF Hartmann stock right now?
What is going on with IVF Hartmann stock in the last 3 months?
Does IVF Hartmann offer dividend payments?
What is the current market capitalization of IVF Hartmann?

IVF Hartmann Holding AG Company Profile

IVF Hartmann Holding AG (VBSN.SW) develops and supplies essential medical products and services. The company focuses on wound management, hygiene, and patient care solutions. It serves healthcare professionals, institutions, and patients across various clinical and home care settings. Its comprehensive offerings aim to enhance patient well-being, support efficient clinical operations, and prevent infections.

The company provides a comprehensive portfolio within wound management. This includes advanced wound dressings, traditional bandages, and fixation products designed for diverse applications. These offerings support the healing process for acute wounds, chronic ulcers, and surgical incisions. They also help manage complex wound conditions effectively, promoting faster recovery and reducing complications. The products address needs ranging from basic first aid to specialized clinical applications in hospitals and long-term care facilities.

In the hygiene and disinfection domain, IVF Hartmann Holding AG offers a broad range of solutions. These products include disinfectants for surfaces and medical instruments, as well as hand hygiene products like sanitizers and soaps. The company also supplies surgical drapes, gowns, and other protective apparel. These items are crucial for maintaining sterile environments and preventing healthcare-associated infections in operating rooms and patient care areas. They support rigorous infection control protocols across various medical facilities.

Beyond wound care and hygiene, the company provides various medical supplies for patient care. These encompass products for incontinence management, such as absorbent pads, pants, and skincare solutions. It also offers items for patient positioning, fixation, and protection during medical procedures and recovery. These supplies contribute significantly to overall patient comfort, safety, and dignity in both institutional and home care settings.

IVF Hartmann Holding AG serves a diverse customer base, including hospitals, clinics, pharmacies, and individual consumers. The company distributes its products through a combination of direct sales forces, online channels, and an extensive network of distribution partners. Revenue primarily derives from product sales and service fees, with some recurring elements from long-term supply agreements and maintenance contracts, reaching customers through direct and channel sales globally.

Sector:Health Care
Country:Switzerland
Industry:
Address:Victor von Bruns-Strasse 28, NEUHAUSEN AM RHEINFALL
Employees:279
Website:ivf.hartmann.info

Pros

Inelastic demand for essential medical consumables

Demographic tailwind from aging global population

High regulatory barriers to market entry

Established healthcare distribution channel access

Diversified product portfolio across medical segments

Cons

Intense competition from global healthcare corporations

Persistent pricing pressure from healthcare payers

Exposure to raw material cost fluctuations

High costs of continuous regulatory compliance

Risk of product obsolescence from medical innovation

Pros

Cons

Company

AI Score

Compare

PHH2.FPaul Hartmann AG

STMN.SWStraumann Holding AG

SHL.DESiemens Healthineers AG

FAGR.BRFagron NV

INM.WAInventionmed SA

Company

AI Score

Compare

VBSN.SW Top 10 Industry Stocks

Health Care Equipment & Supplies

	Company	AI Score	Compare
1	PRM.MCPrim SA
2	VBSN.SWIVF Hartmann Holding AG
3	MRC.WAMercator Medical SA
4	MOVE.SWMedacta Group SA
5	OTO.MIOtofarma SpA
6	ALSGD.PASpineguard SA
7	LXB.STLuxbright AB
8	RUA.LRua Life Sciences PLC
9	EL.PAEssilorLuxottica SA
10	PHH2.FPaul Hartmann AG

	Company	AI Score	Compare

VBSN.SW Top 10 Sector Stocks

Health Care

	Company	AI Score	Compare
1	REC.MIRecordati Industria Chimica e Farmaceutica SpA
2	FAE.MCFaes Farma SA
3	ALK B.COALK-Abello A/S
4	ANCR.LAnimalcare Group plc
5	LKMNH.E.ISLokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS
6	LAB.MCLabiana Health SA
7	TNZTP.E.ISTapdi Oksijen Ozel Saglik ve Egitim Hizmetleri Sanayi Ticaret AS
8	MPARK.E.ISMLP Saglik Hizmetleri AS
9	PRM.MCPrim SA
10	AEVS.SWAevis Victoria SA

	Company	AI Score	Compare

VBSN.SW Stock AI Analysis